Business Humacyte, a Durham biotech firm with Duke ties, valued at $1.1B after going public By admin Posted on February 17, 2021 Share Tweet Share Share Email Comments Humacyte, a Durham-based biotech founded by a Duke professor, makes bioengineered human tissue. Powered by WPeMatico Related Items:featured business Share Tweet Share Share Email Recommended for you EXPLAINER: UN vaccine plan is underway, but problems remain Telehealth Startups to Watch Fed’s Powell says state and local governments are rebounding faster right now than during the financial crisis Click to comment Leave a Reply Cancel replyYour email address will not be published. Required fields are marked *Comment Name * Email * Website Save my name, email, and website in this browser for the next time I comment. Notify me of follow-up comments by email. Notify me of new posts by email. This site uses Akismet to reduce spam. Learn how your comment data is processed.